Approval · Notice of Compliance 973 · 2000
ACTACEL (CLASSIC): Notice of Compliance 973
Issued April 4, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 973
- Date
- April 4, 2000
- Company
- Aventis Pasteur LimitedSwiftwater, Pennsylvania, United States
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Active immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACTACEL (CLASSIC) | 02238683 | Cancelled Pre Market |
Medicinal ingredients
- DIPHTHERIA TOXOID 15 LF per 0.5ML
- POLYRIBOSE RIBITOL PHOSPHATE POLYSACCHARIDE (PRP) 10 MCG per 0.5ML
- TETANUS PROTEIN 20 MCG per 0.5ML
- TETANUS TOXOID 5 LF per 0.5ML
- PERTUSSIS TOXOID 10 MCG per 0.5ML
- FILAMENTOUS HAEMAGGLUTININ 5 MCG per 0.5ML
- PERTACTIN 3 MCG per 0.5ML
- FIMBRIAE 5 MCG per 0.5ML